Disease-Modifying Drugs for Multiple Sclerosis and Association With Survival.
Huah Shin NgFeng ZhuElaine KingwellShenzhen YaoOkechukwu EkumaCharity EvansJohn D FiskRuth Ann MarrieYinshan ZhaoHelen TremlettPublished in: Neurology(R) neuroimmunology & neuroinflammation (2022)
Our study demonstrates an association between the DMDs for MS and improved survival in the real-world setting.